Results 141 to 150 of about 11,167,014 (325)
Defining the role of αC helix interactions in the activation of the integrin αI domain
The α2I domain of the α2β1 integrin contains a distinctive αC helix and a conserved Arg288‐Glu318 ion pair that stabilizes the closed state of the domain. Disruption of this ion pair in the activated α2I variant unwinds the αC helix, which allows interaction with additional collagen‐binding sites increasing collagen binding.
Liisa Pösö +7 more
wiley +1 more source
A case of special blood type with discrepancy between ABO genotype and serological results
[Objective] To analyze the cause of discrepancy between ABO genotype B102/O01 and serological results in one case by PCR-SSP, to clarify the serological characteristics of this special blood group, and to explore relevant blood transfusion strategies ...
CUI Limin, ZHANG Wei, JIA Wenting
core +1 more source
Performing Large‐Scale Genetic Analysis in the Bleeding Disorders Community
ABSTRACT Inherited bleeding disorders encompass a diverse group of conditions caused by genetic defects affecting coagulation factors, fibrinogen, von Willebrand factor, or platelet function. Despite major advances in quantitative and functional laboratory assays, a substantial diagnostic gap remains, particularly in patients with mild or atypical ...
Anna R. Blankstein +6 more
wiley +1 more source
Acute Myeloblastic Leukemia with Erythrophagocytosis and ABO Blood Type Change [PDF]
A 61-year-old Japanese male developed acute myeloblastic leukemia in which ABO blood type change and erythrophagocytosis by leukemic myeloblasts ware simultaneously observed.
Inoue, Masamitsu +5 more
core
ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini +4 more
wiley +1 more source
Objective To investigate the distribution features of dyslipidemia within the ABO blood group system Suburbs of Shanghai, China. Methods This retrospective cross-sectional study analyzed 12,926 sets of blood lipid data associated with the ABO blood group
Jing Chen, Shanshan Chen, Tao Xiao
doaj +1 more source
ABSTRACT Background Von Willebrand disease (VWD) is the most common inherited bleeding disorder, yet its diagnosis and management remain heterogeneous across Europe due to variable access to diagnosis and care. Aim To characterize diagnostic and treatment practices for VWD across European hemophilia centers.
Omid Seidizadeh +10 more
wiley +1 more source
Serological and genetic analysis of a Bel subtype caused by a novel 29insG mutation: a case report
Objective To investigate the serological characteristics and molecular mechanism of a case of Bel subtype. Methods Serological method was used to analyze the ABO blood group of the patient, absorption and elution test was used to detect the weak antigen ...
ZHOU Renlong +2 more
doaj +1 more source
DIELECTROPHORETIC CHARACTERIZATION OF ABO BLOOD TYPE, FREQUENCY AND AC FIELD STRENGTH OF ERYTHROCYTES [PDF]
This research investigates the role of ABO blood type of erythrocytes in their dielectrophoretic response. The dielectrophoresis of erythrocytes of positive ABO blood types was studied at 5 V (peak to peak) and 1 MHz frequency AC field.
Daggolu, Prashant Reuben
core
Shared Decision‐Making in Haemophilia Involves More Treatment Differentiators in 2026
ABSTRACT Introduction Shared decision‐making regarding treatment choice in haemophilia care has become increasingly more complex and essential due to the availability of several innovative therapeutics that are characterized by their own advantages and limitations, which need to be tailored to individual patient needs.
Quentin Van Thillo +2 more
wiley +1 more source

